Sorafenib

Sorafenib is a phenylurea in which one nitrogen is substituted by a 4-chloro-3-trifluoromethylphenyl group and the other by a phenyl group substituted at the para position with a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. It functions as an antineoplastic agent, a non-specific serine/threonine protein kinase inhibitor, a tyrosine kinase inhibitor, an angiogenesis inhibitor, an anticoronaviral agent, and a ferroptosis inducer. It is a pyridinecarboxamide, a monochlorobenzene, an aromatic ether, a (trifluoromethyl)benzene, and a phenylurea.